Study of Neoadjuvant Nivolumab in Patients With Non-metastatic Stage II-IV Clear Cell Renal Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Bristol-Myers Squibb
Related studies linked through entity extraction aliases.
A Study of Nivolumab in Advanced Non-Small Cell Lung Cancer (NSCLC)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study of Brentuximab Vedotin Combined With Nivolumab for Relapsed or Refractory Hodgkin Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Study of Nivolumab in Unresectable Advanced or Recurrent Esophageal Cancer
- Status
- COMPLETED
- Phase
- PHASE3
A Study to Compare the Pharmacokinetics of Belatacept Using Active Pharmaceutical Ingredient Manufactured by Process E Relative to Process C
- Status
- COMPLETED
- Phase
- PHASE1
Apixaban in Atrial Fibrillation Registry
- Status
- COMPLETED
- Phase
- N/A
Study to Assess Changes in the Immune Profile in Adults With Early Rheumatoid Arthritis
- Status
- COMPLETED
- Phase
- PHASE4
A Phase 2b Evaluation of Daclatasvir/Sofosbuvir in Non-Cirrhotic Treatment Naive Subjects With Genotype 1, 2, 3 and 4 Chronic Hepatitis C Virus Coinfected With Human Immunodeficiency Virus (HIV-1)
- Status
- WITHDRAWN
- Phase
- PHASE2
Relationship Between Tumor Mutation Burden and Predicted Neo-antigen Burden in Patients With Advanced Melanoma or Bladder Cancer Treated With Nivolumab or Nivolumab Plus Ipilimumab (CA209-260)
- Status
- COMPLETED
- Phase
- PHASE2
A Randomized, Open-Label Study of Daclatasvir and Sofosbuvir With or Without Ribavirin for 8 Weeks in Treatment-Naïve, Non-cirrhotic Subjects Infected With Chronic Hepatitis C Virus (HCV) Genotype 3
- Status
- WITHDRAWN
- Phase
- PHASE2
Vaccination Against Pneumococcal in Naïve Abatacept Rheumatoid Arthritis Patients
- Status
- COMPLETED
- Phase
- NA
Eliquis (VTE Treatment and Prevention of Recurrent VTE) rPMS
- Status
- COMPLETED
- Phase
- N/A
Frequency and Severity of Pleural Effusion Associated With the Use of Dasatinib in Patients With Chronic Myeloid Leukemia. A Descriptive, Mexican Multicenter Study
- Status
- COMPLETED
- Phase
- N/A
A Comparative Study in Chinese Subjects With Chemotherapy Naïve Stage IV Melanoma Receiving Ipilimumab (3 mg/kg) vs. Dacarbazine
- Status
- COMPLETED
- Phase
- PHASE3
A Study of a Nucleoside Sparing Regimen in HIV-1 Infected Patients With Detectable Viremia
- Status
- COMPLETED
- Phase
- PHASE2
Expanded Access Single Named Patient Program With Elotuzumab (BMS-901608) for the Treatment of Patient R-A With Relapsed/Refractory Multiple Myeloma
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
A Study of BMS-986171 in Healthy People to Assess Safety, to Measure Blood Levels of Drug, and to Find Out What the Drug Does to the Body
- Status
- COMPLETED
- Phase
- PHASE1
An Investigational Immuno-therapy Study of Nivolumab, or Nivolumab in Combination With Ipilimumab, or Placebo in Patients With Extensive-Stage Disease Small Cell Lung Cancer (ED-SCLC) After Completion of Platinum-based Chemotherapy
- Status
- COMPLETED
- Phase
- PHASE3
HuMax-IL8 (Interleukin8) in Patients With Advanced Malignant Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Safety Study of BMS-986165 in Healthy Subjects and to Treat Psoriasis
- Status
- COMPLETED
- Phase
- PHASE1